Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

FLO-PRED

PREDNISOLONE ACETATE

Standard Dose
EQ 15MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview FLO-PRED is listed in Drugs@FDA under application 022067 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE Form and strength SUSPENSION;ORAL - EQ 15MG BASE/5ML Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2024-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLO-PRED is listed in Drugs@FDA under application 022067 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE Form and strength SUSPENSION;ORAL - EQ 15MG BASE/5ML Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2024-06-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FLO-PRED (PREDNISOLONE ACETATE) | Drug Monograph | MedicHelpline